# PLUVICTO

NDC: 0078-1217
Generic name: lutetium Lu 177 vipivotide tetraxetan
Labeler / Manufacturer: Novartis Pharmaceuticals Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20220323

FDA application: NDA215833

## Active ingredients

- LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN: 27 mCi/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0078-1217"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0078-1217
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=14908037-2892-4d98-a053-253ce35afb1a